251 related articles for article (PubMed ID: 9179393)
21. The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.
Bainbridge AD; Macfadyen RJ; Stark S; Lees KR; Reid JL
Br J Clin Pharmacol; 1993 Oct; 36(4):323-30. PubMed ID: 12959310
[TBL] [Abstract][Full Text] [Related]
22. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
Leenen FH; Myers MG; Joyner CD; Toal CB
Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
[TBL] [Abstract][Full Text] [Related]
25. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
[TBL] [Abstract][Full Text] [Related]
26. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
27. Replacement of salt by a novel potassium- and magnesium-enriched salt alternative improves the cardiovascular effects of ramipril.
Mervaala EM; Paakkari I; Laakso J; Nevala R; Teräväinen TM; Fyhrquist F; Vapaatalo H; Karppanen H
Br J Pharmacol; 1994 Apr; 111(4):1189-97. PubMed ID: 8032605
[TBL] [Abstract][Full Text] [Related]
28. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 diabetes (ATTEST) study.
Katayama S; Kawamori R; Iwamoto Y; Saito I; Kuramoto K;
Hypertens Res; 2008 Aug; 31(8):1499-508. PubMed ID: 18971523
[TBL] [Abstract][Full Text] [Related]
29. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
30. [Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension].
Laganović M
Lijec Vjesn; 2010; 132(3-4):94-8. PubMed ID: 20540436
[TBL] [Abstract][Full Text] [Related]
31. Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER.
Scholze J; Bauer B; Massaro J
Clin Exp Hypertens; 1999 Nov; 21(8):1447-62. PubMed ID: 10574423
[TBL] [Abstract][Full Text] [Related]
32. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
33. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
34. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
de Gasparo M; Hess P; Nuesslein-Hildesheim B; Bruneval P; Clozel JP
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
[TBL] [Abstract][Full Text] [Related]
35. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
Linz W; Schäfer S; Afkham F; Gerl M; Schmidts HL; Rütten H
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
[TBL] [Abstract][Full Text] [Related]
36. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
37. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic comparisons of enalapril and felodipine and their combination.
Morgan TO; Anderson A
Kidney Int Suppl; 1992 May; 36():S78-81. PubMed ID: 1614072
[TBL] [Abstract][Full Text] [Related]
39. Arterial responses to bradykinin after ramipril therapy in experimental hypertension.
Hutri-Kähönen N; Pörsti I; Wu X; Tolvanen JP; Sallinen K; Kähönen M
Pharmacol Toxicol; 1997 Oct; 81(4):190-6. PubMed ID: 9353850
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.
Abdel-Zaher AO; Elkoussi AE; Abudahab LH; Elbakry MH; Elsayed EA
Fundam Clin Pharmacol; 2012 Dec; 26(6):701-11. PubMed ID: 21913974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
